Clinical Trials Logo

Methadone clinical trials

View clinical trials related to Methadone.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05985850 Not yet recruiting - Opioid Use Disorder Clinical Trials

Evaluating Tetrahydrocannabinol as an Adjunct to Opioid Agonist Therapy

THC-MMT
Start date: January 2024
Phase: Phase 2
Study type: Interventional

This pilot study will evaluate the feasibility and safety of using 1:1 tetrahydrocannabinol (THC):Cannabidiol (CBD) cannabis oil as an adjunct therapy to methadone-based Opioid Agonist Therapy (OAT) for individuals with opioid use disorder (OUD) in a community setting.

NCT ID: NCT05075265 Not yet recruiting - Clinical trials for Cardiopulmonary Bypass

Pharmacokinetics of Methadone in Adults Undergoing Cardiac Surgery With Extracorporeal Circulation

Start date: October 2, 2021
Phase:
Study type: Observational

In cardiac surgery, the establishment of Cardiopulmonary bypass (CPB) involves profound changes that can alter the pharmacokinetics and clinical response to drugs. Methadone has characteristics that make it attractive for the management of postoperative pain, however, to date there are no pharmacokinetic or pharmacodynamic studies that allow guidance on how to perform the dosage and dose adjustment of methadone in patients undergoing cardiopulmonary bypass. The main of this study is to describe the pharmacokinetics of methadone in adult patients undergoing cardiac surgery with extracorporeal circulation. A pharmacokinetic clinical study will be proposed. Drug concentrations will be measured at different times, estimating how plasma levels vary before, during and after CPB. For the plasma methadone analysis, 10 blood samples will be taken from each patient following a pre-established schedule. They will be analyzed using a high performance liquid chromatography (HPLC) spectrofluorometric method. Changes in volumes, clearance, and other covariates associated with CPB are not expected to significantly affect methadone plasma concentrations.